HBA1C REDUCTION WITH DIGITAL HEALTH DEVICES IN TYPE 2 DIABETES (T2DM): A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

被引:0
|
作者
Lee, F. [1 ]
Han-Burgess, E. [2 ]
Kennedy, A. [1 ]
Serafini, P. [3 ]
Pourrahmat, M. M. [3 ]
Breznen, B. [3 ]
机构
[1] Sanofi, Bridgewater, NJ USA
[2] Sanofi, Cambridge, MA USA
[3] Evidinno Outcomes Res Inc, Vancouver, BC, Canada
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
MT2
引用
收藏
页码:S297 / S297
页数:1
相关论文
共 50 条
  • [1] HbA1c and Prediction of Type 2 Diabetes (T2DM) in Children and Adults
    Vijayakumar, Pavithra
    Nelson, Robert G.
    Hanson, Robert L.
    Knowler, William C.
    Sinha, Madhumita
    DIABETES, 2016, 65 : A65 - A65
  • [2] Effect of garlic supplement in the management of type 2 diabetes mellitus (T2DM): a meta-analysis of randomized controlled trials
    Wang, Juan
    Zhang, Xiuming
    Lan, Haili
    Wang, Weijia
    FOOD & NUTRITION RESEARCH, 2017, 61
  • [3] Modelling HbA1c Trajectory in Patients with Type 2 Diabetes Mellitus (T2DM)
    Mcewan, Phil
    Fellows, Jonathan
    Yapp, Rhiannon
    Bergenheim, Klas
    Qin, Lei
    Varol, Nebibe
    Bennett, Hayley
    Gordon, Jason
    DIABETES, 2016, 65 : A322 - A322
  • [4] Clustering of HBA1C longitudinal trajectories in type 2 diabetes mellitus (T2DM)
    De la Torre, Adrian Martinez
    Faquetti, Maria Luisa Marques De Sa
    Perez-Cruz, Fernando
    Weiler, Stefan
    Burden, Andrea
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 60 - 60
  • [5] Treatment Progression and Impact of HbA1C in Type 2 Diabetes (T2DM) Patients
    Dibello, Julia R.
    Levy, Brian
    Mehra, Maneesha
    DIABETES, 2010, 59 : A623 - A624
  • [6] Abnormally low HbA1c in type 2 diabetes mellitus (T2DM): Familiar study
    Gargallo, Manuel A.
    Familiar, Cristina
    Gonzalez, Fernando A.
    Villegas, Ana
    DIABETES, 2006, 55 : A112 - A113
  • [7] Is HbA1c a valid surrogate for mortality in type 2 diabetes? Evidence from a meta-analysis of randomized trials
    Christina Baechle
    Wiebke Scherler
    Alexander Lang
    Tim Filla
    Oliver Kuss
    Acta Diabetologica, 2022, 59 : 1257 - 1263
  • [8] Is HbA1c a valid surrogate for mortality in type 2 diabetes? Evidence from a meta-analysis of randomized trials
    Baechle, Christina
    Scherler, Wiebke
    Lang, Alexander
    Filla, Tim
    Kuss, Oliver
    ACTA DIABETOLOGICA, 2022, 59 (10) : 1257 - 1263
  • [9] Effect of diabetes self-management education (DSME) on glycated hemoglobin (HbA1c) level among patients with T2DM: Systematic review and meta-analysis of randomized controlled trials
    Bekele, Bayu Begashaw
    Negash, Samuel
    Bogale, Biruk
    Tesfaye, Melkamsew
    Getachew, Dawit
    Weldekidan, Fekede
    Balcha, Behailu
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (01) : 177 - 185
  • [10] Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trials
    Giugliano, D.
    Maiorino, M.
    Bellastella, G.
    Chiodini, P.
    Esposito, K.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (05) : 602 - 612